Multicentre review of readmission rates within 30 days of discharge following lung cancer surgery

2019 ◽  
Vol 28 (17) ◽  
pp. S16-S22
Author(s):  
Maureen King ◽  
Amy Kerr ◽  
Sandra Dixon ◽  
Sarah Taylor ◽  
Alison Smith ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Postoperative Complications ◽  
Thoracic Surgery ◽  
Primary Lung Cancer ◽  
Lung Cancer Surgery ◽  
Cancer Surgery ◽  
Limited Data ◽  
Readmission Rates ◽  
Surgery Group ◽  
The Uk

Postoperative complications following curative lung cancer surgery are well recognised, but there is limited data on 30-day readmission rates. The UK Thoracic Surgery Group conducted a multicentre review over a 3-month period to assess readmission rates. Overall readmission among the 268 patients who had undergone primary lung cancer surgery was 30 (11%); 14/30 of readmissions occurred within 7 days of discharge, with 13/30 patients readmitted to a hospital that had not performed the surgery. The causes of readmission were mainly pulmonary related (16/30). Readmission was associated with being discharged with a pleural drain 11/30 (P<0.01), having two or more postoperative complications 11/30 (P<0.01) and a patient's readiness for discharge 9/30 (P=0.001). There was a trend toward an association with smoking 13/30 (P=0.18). The authors suggest that a greater focus on patients presenting with characteristics associated with readmission, and incorporating a patient's readiness for discharge, may reduce readmission, although more studies are needed.

Risk Stratification According to the Prognostic Nutritional Index for Predicting Postoperative Complications After Lung Cancer Surgery

2018 ◽  
Vol 25 (5) ◽  
pp. 1254-1261 ◽  
Author(s):  
Satoru Okada ◽  
Junichi Shimada ◽  
Satoshi Teramukai ◽  
Daishiro Kato ◽  
Hiroaki Tsunezuka ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Postoperative Complications ◽  
Risk Stratification ◽  
Lung Cancer Surgery ◽  
Prognostic Nutritional Index ◽  
Cancer Surgery ◽  
Nutritional Index

Minimally Invasive Lung Cancer Surgery Performed by Thoracic Surgeons as Effective as Thoracotomy

2018 ◽  
Vol 36 (23) ◽  
pp. 2378-2385 ◽  
Author(s):  
Daniel J. Boffa ◽  
Andrzej S. Kosinski ◽  
Anthony P. Furnary ◽  
Sunghee Kim ◽  
Mark W. Onaitis ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Minimally Invasive ◽  
Thoracic Surgery ◽  
Lung Cancer Surgery ◽  
Hazard Ratio ◽  
Cancer Surgery ◽  
Stage I ◽  
Invasive Approach ◽  
Longitudinal Outcome ◽  
Stage I Lung Cancer

Purpose The prevalence of minimally invasive lung cancer surgery using video-assisted thoracic surgery (VATS) has increased dramatically over the past decade, yet recent studies have suggested that the lymph node evaluation during VATS lobectomy is inadequate. We hypothesized that the minimally invasive approach to lobectomy for stage I lung cancer resulted in a longitudinal outcome that was not inferior to thoracotomy. Patients and Methods Patients > 65 years of age who had undergone lobectomy for stage I lung cancer between 2002 and 2013 were analyzed within the Society of Thoracic Surgeons General Thoracic Surgery Database, which had been linked to Medicare data, as part of a retrospective-cohort, noninferiority study. Results A total of 10,597 patients with clinical stage I lung cancer who underwent lobectomy were evaluated (4,448 patients underwent thoracotomy, and 6,149 underwent VATS). VATS patients had a more favorable distribution of all health-related variables, including pulmonary function (59% of VATS patients had intact spirometry v 51% of thoracotomy patients; P < .001). Cox proportional hazards models were performed over two eras to account for an evolving practice standard. The mortality risk associated with the VATS approach was not greater than thoracotomy in either the earlier era (2002 to 2008; hazard ratio, 0.97; 95% CI, 0.87 to 1.09; P = .62) or the more recent era (2009 to 2013; hazard ratio, 0.84; 95% CI, 0.75 to 0.93; P < .001). Kaplan-Meier survival estimates of 2,901 propensity-matched VATS-thoracotomy pairs demonstrated that the 4-year survival associated with VATS (68.6%) was modestly superior to thoracotomy (64.8%; P = .003). The analyses detailed above were replicated in a separate cohort of pathologic stage I patients with similar findings. Conclusion The long-term efficacy of lobectomy for stage I lung cancer performed using the VATS approach by board-certified thoracic surgeons does not seem to be inferior to that of thoracotomy.

Physical activity as a predictor of postoperative complications among patients undergoing lung cancer surgery

2017 ◽  
Author(s):  
Ana Gomez-Bastero Fernandez ◽  
Estefania Luque Crespo ◽  
Virginia Almadana Pacheco ◽  
Maria ◽  
Agustin ◽  
...  
Keyword(s):  
Physical Activity ◽  
Lung Cancer ◽  
Postoperative Complications ◽  
Lung Cancer Surgery ◽  
Cancer Surgery

B-Type Natriuretic Peptide-Guided Risk Assessment for Postoperative Complications in Lung Cancer Surgery

2015 ◽  
Vol 39 (5) ◽  
pp. 1092-1098 ◽  
Author(s):  
Takashi Nojiri ◽  
Masayoshi Inoue ◽  
Yasushi Shintani ◽  
Yukiyasu Takeuchi ◽  
Hajime Maeda ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Risk Assessment ◽  
Postoperative Complications ◽  
Natriuretic Peptide ◽  
Lung Cancer Surgery ◽  
Cancer Surgery

scholarly journals Protective ventilation during anaesthesia reduces major postoperative complications after lung cancer surgery

2018 ◽  
Vol 35 (10) ◽  
pp. 727-735 ◽  
Author(s):  
Emmanuel Marret ◽  
Raphael Cinotti ◽  
Laurence Berard ◽  
Vincent Piriou ◽  
Jacques Jobard ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Postoperative Complications ◽  
Lung Cancer Surgery ◽  
Protective Ventilation ◽  
Cancer Surgery

scholarly journals Lung cancer resection and postoperative outcomes in COPD: A single-center experience

2020 ◽  
Vol 17 ◽  
pp. 147997312092543
Author(s):  
Emma Roy ◽  
Justine Rheault ◽  
Marc-Antoine Pigeon ◽  
Paula Antonia Ugalde ◽  
Christine Racine ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Postoperative Complications ◽  
Lung Cancer Surgery ◽  
Cancer Surgery ◽  
Airflow Limitation ◽  
Chronic Obstructive ◽  
Term Survival ◽  
Long Term Survival ◽  
Cancer Resection

Chronic obstructive pulmonary disease (COPD) increases postoperative morbidity and is associated with diminished long-term survival after lung cancer resection. Whether this is also true for mild-to-moderate COPD is uncertain. We conducted a retrospective analysis of all the patients who underwent lung cancer surgery between 2002 and 2012 in a university-affiliated hospital. The severity of airflow limitation was stratified according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) from stage 1 to 4. Data from 1456 cases of lung cancer surgery were reviewed and 1126 patients were included in the study: 672 (59.7%) patients had COPD (GOLD 1, n = 340; GOLD 2, n = 282; GOLD 3, n = 50) and 454 patients had a normal spirometry (controls). Following lung cancer resection, patients with COPD had a higher rate of postoperative morbidities of any kind ( p < 0.0001), in particular, pneumonia (7.0% vs. 3.7%; p = 0.0251) and prolonged air leak (17.0% vs. 8.2%; p < 0.0001) than controls. In-hospital mortality was increased in GOLD 3 COPD but the incidence of other postoperative complications was not influenced by COPD severity. Neither COPD nor its severity influenced long-term survival in this population. To conclude, patients with COPD undergoing lung cancer surgery were at higher risk of postoperative complications than patients with normal respiratory function but the procedure was considered safe. The presence of COPD itself did not influence long-term survival. The results of our study apply mainly to patients with a GOLD 1 and 2 COPD since only a small number of patients with GOLD 3 COPD were involved.

Sign in / Sign up

Export Citation Format

Share Document